Pharmaceutical company Pfizer Inc. (NYSE: PFE) Tuesday reaffirmed its financial outlook for fiscal 2024 and provided guidance for fiscal 2025.
- The company said it achieved the goal of $4 bln in cost savings through 2024 and anticipates an additional $500 mln in savings in 2025, from the ongoing cost realignment program
- Pfizer continues to expect fiscal 2024 revenue in the range of $61 billion to $64 billion and confirmed its full-year adjusted EPS guidance of $2.75-2.95
- For fiscal 2025, the management expects revenue to be in the range of $61 billion to $64 billion and adjusted EPS between $2.80 and $3.00
- It is looking for adjusted EPS operational growth of 10-18% for FY25, from the midpoint of the 2024 guidance after adjusting for non-recurring items
- Phase I of the company’s manufacturing optimization program is on track to deliver initial net cost savings in the latter part of 2025, towards the goal of improving gross margin performance
- Adjusted SI&A expense is expected to be in the range of $13.3 to $14.3 billion in FY25, and adjusted R&D expenses between $10.7 billion and $11.7 billion
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Earnings Preview: Nike (NKE) looks poised to report weak Q2 results
Nike, Inc. (NYSE: NKE) is set to report second-quarter results on Thursday, with analysts predicting a double-whammy of year-over-year decline in sales and profit. The company has been going through
FedEx (FDX) is preparing to report Q2 results. Here’s what to expect
FedEx Corporation (NYSE: FDX) has merged its operating segments into a single entity as part of an extensive reorganization aimed at cutting costs and achieving operational efficiency. The market is
What to expect when Lamb Weston (LW) reports its Q2 2025 earnings results
Shares of Lamb Weston Holdings, Inc. (NYSE: LW) were down over 1% on Friday. The stock has gained 13% over the past three months. The frozen potato products maker is
